Edkem Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2016.
2016 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Edkem Pharmaceuticals Limited

Edkem Pharmaceuticals Limited, a active public limited company, was established on 06 July 2016 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2016PLC092826. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.50 Cr and a paid-up capital of ₹6.47 Cr.

Formerly known as Edkem Pharmaceuticals Private Limited. It upholds a compliant status. Employing 69 professional, Its leadership includes Jitendra Ranpara (Director), Basant Santoshkumar Agrawal (Director), Santoshkumar Jamnaprasad Agrawal (Director). Past directors included Santoshkumar Jamunaprasad Agrawal, Jitendra Ranpara, Ankita Basant Agrawal. It holds ₹34.56 Cr open charges and no settled loans. Its latest AGM occurred on 04 September 2025, with the balance sheet filed on 31 March 2025. It is based at 145-148, (M9 - M12), Gallops Ind. Park - 2, Vi., Chachrawadi, Vasna, Ta. Sanand, Ahmedabad, Gujarat, 380007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2016PLC092826

  • Registration Number

    092826

  • Incorporation Date

    06 July 2016

  • Authorized Capital

    ₹6.50 Cr

  • Paid-Up Capital

    ₹6.47 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.50 Cr
  • Paid Up Capital ₹ 6.47 Cr
  • Company Age 9 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 34.56 Cr
  • Revenue Growth **** 14.40%
  • Profit Growth **** 18.47%
  • Ebitda **** 23.74%
  • Net Worth 31.01%
  • Total Assets **** 10.33%
Company report

Edkem Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Edkem Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Edkem Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Jitendra Ranpara Director 23 Mar 2019 Current
Basant Santoshkumar Agrawal Director 06 Jul 2016 Current
Santoshkumar Jamnaprasad Agrawal Director 06 Jul 2016 Current
Ankita Basant Agrawal Director 12 Jun 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director - Past
Pramod Abcsdd Additional Director 29 Apr 2019 Past
Pramod Abcsdd Additional Director 12 Jun 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Edkem Pharmaceuticals.

Edkem Pharmaceuticals Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 14.4% increase. The company also saw a substantial improvement in profitability, with a 18.47% increase in profit. The company's net worth Soared by an impressive increase of 31.01%.

Edkem Pharmaceuticals revenue growth over time
Edkem Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 14.40%
*******
*******
*******
*******
Revenue from Operations
*******
 15.75%
*******
*******
*******
*******
Total Assets
*******
 10.33%
*******
*******
*******
*******
Profit or Loss
*******
 18.47%
*******
*******
*******
*******
Net Worth
*******
 31.01%
*******
*******
*******
*******
EBITDA
*******
 23.74%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Edkem Pharmaceuticals?

In 2024, Edkem Pharmaceuticals had a promoter holding of 99.07% and a public holding of 0.93%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹345,600,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 34.56 Cr
Latest Charge Details
Date Lender Amount Status
12 Dec 2017 Axis Bank Limited ₹17.28 Cr Open
08 Dec 2017 Axis Bank Limited ₹17.28 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Edkem Pharmaceuticals?

Edkem Pharmaceuticals has a workforce of 69 employees as of Jan 18, 2026. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Edkem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edkem Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Edkem Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Edkem Pharmaceuticals Limited last Annual general meeting of members was held on 04 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 17.28 Cr registered on 12 Dec 2017 with Charge ID 100142248 was modified on 14 Jul 2025. was completed.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 17.28 Cr registered on 08 Dec 2017 with Charge ID 100142247 was modified on 02 Jul 2025. was completed.

  • Balance Sheet

    The activity Edkem Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Director Appointment

    The activity Jitendra Ranpara was appointed as a Director was appointed as a Director on 23 Mar 2019 & has been associated with this company since 6 years 10 months . was completed.

  • Director Appointment

    The activity Ankita Basant Agrawal was appointed as a Director was appointed as a Director on 12 Jun 2018 & has been associated with this company since 7 years 8 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Edkem Pharmaceuticals Limited?

The CIN of Edkem Pharmaceuticals Limited is U24230GJ2016PLC092826.

Where is Edkem Pharmaceuticals Limited headquartered?

Edkem Pharmaceuticals Limited is headquartered at 145-148, (M9 - M12), Gallops Ind. Park - 2, Vi., Chachrawadi, Vasna, Ta. Sanand, Ahmedabad, Gujarat, 380007.

When was Edkem Pharmaceuticals Limited incorporated?

Edkem Pharmaceuticals Limited was incorporated on 06 July 2016.

Who are the current directors of Edkem Pharmaceuticals Limited?

The current directors of Edkem Pharmaceuticals Limited are

What is the primary industry of Edkem Pharmaceuticals Limited?

The primary industry of Edkem Pharmaceuticals Limited is Manufacturing.

Is Edkem Pharmaceuticals Limited a listed company?

Edkem Pharmaceuticals Limited is unlisted.

What is the capital structure of Edkem Pharmaceuticals Limited?

The authorized capital of Edkem Pharmaceuticals Limited is ₹6.50 Cr, and the paid-up capital is ₹6.47 Cr.

What is the compliance status of Edkem Pharmaceuticals Limited?

The compliance status of Edkem Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available